David Holecek
Healthcare commercialization and analytics leader specializing in oncology
Chicago, Illinois
Summary
Oncology-focused AI entrepreneur: co-founded Wild Type Advocates to build DORIS, a cancer-specific LLM and clinician-facing information platform aiming to streamline oncology decision-making and improve access to up-to-date treatment information. cancerhackerlab+2
Established commercialization and analytics leader in life sciences: founding/managing partner at Integritas Analytics with decades of experience in pharmaceutical commercialization, launch strategy, advanced analytics, and market research—especially in oncology, rare diseases, and orphan drug launches. integritasanalytics+1
Experienced collaborator and contributor to clinical research: credited as a co-author on a 2025 PubMed-indexed survey study examining pill-splitting practices in Parkinson's disease, demonstrating involvement in healthcare research and analytics beyond commercial consulting. nih+1
Business-to-healthcare connector with deep domain expertise: long career spanning consulting, analytics, and product commercialization (including work on high-profile drug launches) and the application of applied AI/ML methods to solve complex HCP and patient research problems. integritasanalytics+1